Stay updated with breaking news from Study Procedure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
26.03.2024 - TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase Technologies Inc. ('Theralase' or the 'Company') (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic ... Seite 1
Theralase(R) to Host Advisory Board Meetings at Canadian Urological ...
Theralase Technologies Inc.: Theralase Releases Quarterly Newsletter ® Technologies Inc. (" TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds (" PDC") and associated drug formulations to safely and effectively destroy various cancers, bacteria and viruses has released the Company's Quarterly Newsletter (" Newsletter") which provides updates on the previous quarter and progress on the Phase II Non-Muscle Invasive Bladder Cancer (" NMIBC") Clinical Study (" Highlights from the Newsletter: Clinic...